{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:30:55Z","timestamp":1765546255012,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:00:00Z","timestamp":1508371200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1029974","APP1074383","APP1061177"],"award-info":[{"award-number":["APP1029974","APP1074383","APP1061177"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VLSCI","award":["VR0182"],"award-info":[{"award-number":["VR0182"]}]},{"name":"European Social Fund, Human Capital, national Cohesion Strategy","award":["UDA-POKL.04.01.01-00-068\/10-00"],"award-info":[{"award-number":["UDA-POKL.04.01.01-00-068\/10-00"]}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10689-017-0050-6","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T00:05:52Z","timestamp":1508371552000},"page":"345-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine"],"prefix":"10.1007","volume":"17","author":[{"given":"Aleksander","family":"Myszka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu","family":"Nguyen-Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Karpinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria M.","family":"Sasiadek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayane","family":"Akopyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fleur","family":"Hammet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Tsimiklis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard J.","family":"Pope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryszard","family":"Slezak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliya","family":"Kitsera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Siekierzynska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-9005","authenticated-orcid":false,"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,19]]},"reference":[{"key":"50_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13053-016-0049-2","volume":"14","author":"MC Southey","year":"2016","unstructured":"Southey MC, Winship I, Nguyen-Dumont T (2016) PALB2: research reaching to clinical outcomes for women with breast cancer. Hered Cancer Clin Pract 14:9. doi:\n10.1186\/s13053-016-0049-2","journal-title":"Hered Cancer Clin Pract"},{"issue":"5","key":"50_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"6","key":"50_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506. doi:\n10.1056\/NEJMoa1400382","journal-title":"N Engl J Med"},{"key":"50_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2016-103839","author":"MC Southey","year":"2016","unstructured":"Southey MC, Goldgar DE, Winqvist R et al (2016) PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet. doi:\n10.1136\/jmedgenet-2016-103839","journal-title":"J Med Genet"},{"issue":"6","key":"50_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S1470-2045(15)70142-7","volume":"16","author":"C Cybulski","year":"2015","unstructured":"Cybulski C, Kluzniak W, Huzarski T et al (2015) Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol 16(6):638\u2013644. doi:\n10.1016\/S1470-2045(15)70142-7","journal-title":"Lancet Oncol"},{"issue":"3","key":"50_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s10897-007-9090-7","volume":"16","author":"JL Berliner","year":"2007","unstructured":"Berliner JL, Fay AM, Practice Issues Subcommittee of the National Society of Genetic Counselors\u2019 Familial Cancer Risk Counseling Special Interest G (2007) Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. J Genet Couns 16(3):241\u2013260. doi:\n10.1007\/s10897-007-9090-7","journal-title":"J Genet Couns"},{"issue":"2","key":"50_CR7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-014-3260-8","volume":"149","author":"T Nguyen-Dumont","year":"2015","unstructured":"Nguyen-Dumont T, Hammet F, Mahmoodi M et al (2015) Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry. Breast Cancer Res Treat 149(2):547\u2013554","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"50_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1751-0473-9-3","volume":"9","author":"BJ Pope","year":"2014","unstructured":"Pope BJ, Nguyen-Dumont T, Hammet F, Park DJ (2014) ROVER variant caller: read-pair overlap considerate variant-calling software applied to PCR-based massively parallel sequencing datasets. Source Code Biol Med 9(1):3. doi:\n10.1186\/1751-0473-9-3","journal-title":"Source Code Biol Med"},{"key":"50_CR9","doi-asserted-by":"publisher","unstructured":"M\u00fcnz M, Ruark E, Renwick A et al (2015) CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinic. Genome Med 7:76. doi:\n                        10.1186\/s\/3073-015-0195-6","DOI":"10.1186\/s\/3073-015-0195-6"},{"key":"50_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. doi:\n10.1002\/0471142905.hg0720s76","journal-title":"Curr Protoc Hum Genet"},{"issue":"3","key":"50_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310\u2013315. doi:\n10.1038\/ng.2892","journal-title":"Nat Genet"},{"key":"50_CR12","doi-asserted-by":"publisher","DOI":"10.1101\/030338","author":"M Lek","year":"2015","unstructured":"Lek M, Karczewski K, Minikel E et al (2015) Analysis of protein-coding genetic variation in 60,706 humans. bioRxiv. doi:\n10.1101\/030338","journal-title":"bioRxiv"},{"key":"50_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2350-11-20","volume":"11","author":"A Dansonka-Mieszkowska","year":"2010","unstructured":"Dansonka-Mieszkowska A, Kluska A, Moes J et al (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11:20. doi:\n10.1186\/1471-2350-11-20","journal-title":"BMC Med Genet"},{"issue":"12","key":"50_CR14","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1158\/1055-9965.EPI-13-0745-T","volume":"22","author":"M Janatova","year":"2013","unstructured":"Janatova M, Kleibl Z, Stribrna J et al (2013) The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer. Cancer Epidemiol Prev Biomark 22(12):2323\u20132332. doi:\n10.1158\/1055-9965.EPI-13-0745-T","journal-title":"Cancer Epidemiol Prev Biomark"},{"key":"50_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13053-016-0046-5","volume":"14","author":"P Wojcik","year":"2016","unstructured":"Wojcik P, Jasiowka M, Strycharz E et al (2016) Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland. Hereditary Cancer Clin Practice 14:5. doi:\n10.1186\/s13053-016-0046-5","journal-title":"Hereditary Cancer Clin Practice"},{"issue":"2","key":"50_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10689-013-9684-1","volume":"13","author":"M Noskowicz","year":"2014","unstructured":"Noskowicz M, Bogdanova N, Bermisheva M et al (2014) Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe. Fam Cancer 13(2):137\u2013142. doi:\n10.1007\/s10689-013-9684-1","journal-title":"Fam Cancer"},{"issue":"4","key":"50_CR17","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/cge.12524","volume":"88","author":"C Cybulski","year":"2015","unstructured":"Cybulski C, Lubinski J, Wokolorczyk D et al (2015) Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland. Clin Genet 88(4):366\u2013370. doi:\n10.1111\/cge.12524","journal-title":"Clin Genet"},{"issue":"4","key":"50_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2217\/bmm.13.143","volume":"8","author":"SV Tavtigian","year":"2014","unstructured":"Tavtigian SV, Chenevix-Trench G (2014) Growing recognition of the role for rare missense substitutions in breast cancer susceptibility. Biomark Med 8(4):589\u2013603. doi:\n10.2217\/bmm.13.143","journal-title":"Biomark Med"},{"issue":"4","key":"50_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/humu.22022","volume":"33","author":"M Tischkowitz","year":"2012","unstructured":"Tischkowitz M, Capanu M, Sabbaghian N et al (2012) Rare germline mutations in PALB2 and breast cancer risk: a population-based study. Hum Mutat 33(4):674\u2013680. doi:\n10.1002\/humu.22022","journal-title":"Hum Mutat"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-017-0050-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-017-0050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-017-0050-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T03:32:00Z","timestamp":1528860720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-017-0050-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,19]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s10689-017-0050-6","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"type":"print","value":"1389-9600"},{"type":"electronic","value":"1573-7292"}],"subject":[],"published":{"date-parts":[[2017,10,19]]}}}